Literature DB >> 3170717

Fatal infection caused by a multiply resistant type 3 pneumococcus.

J B Lawrenson1, K P Klugman, J I Eidelman, A Wasas, S D Miller, J Lipman.   

Abstract

The most virulent pneumococcal serotype (type 3) has not to date been associated with multiple antimicrobial resistance. We report an unusual gastrointestinal presentation of fatal septicemia caused by a multiply resistant type 3 pneumococcus in a setting of increasing prevalence of multiple resistance, including resistance to erythromycin, clindamycin, and tetracycline.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3170717      PMCID： PMC266669          DOI： 10.1128/jcm.26.8.1590-1591.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  INFLUENCE OF DAILY PENICILLIN, TETRACYCLINE, ERYTHROMYCIN, AND SULPHAMETHOXYPYRIDAZINE ON EXACERBATIONS OF BRONCHITIS. A REPORT TO THE RESEARCH COMMITTEE OF THE BRITISH TUBERCULOSIS ASSOCIATION.

Authors:  R S FRANCIS; J R MAY; C C SPICER
Journal:  Br Med J       Date:  1964-03-21

2.  Emergence of multiply resistant pneumococci.

Authors:  M R Jacobs; H J Koornhof; R M Robins-Browne; C M Stevenson; Z A Vermaak; I Freiman; G B Miller; M A Witcomb; M Isaäcson; J I Ward; R Austrian
Journal:  N Engl J Med       Date:  1978-10-05       Impact factor: 91.245

3.  Meningitis and pneumonia due to novel multiply resistant pneumococci.

Authors:  K P Klugman; H J Koornhof; V Kuhnle; S D Miller; P J Ginsburg; A C Mauff
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-15

4.  Arterial oxygen tension values in normal adults at an altitude of 1763 metres.

Authors:  D J Kanarek; H I Goldman; S Zwi
Journal:  S Afr Med J       Date:  1972-03-18

Review 5.  Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups.

Authors:  J B Robbins; R Austrian; C J Lee; S C Rastogi; G Schiffman; J Henrichsen; P H Mäkelä; C V Broome; R R Facklam; R H Tiesjema
Journal:  J Infect Dis       Date:  1983-12       Impact factor: 5.226

6.  Community-acquired pneumonia due to penicillin-resistant pneumococci.

Authors:  C Feldman; J M Kallenbach; S D Miller; J R Thorburn; H J Koornhof
Journal:  N Engl J Med       Date:  1985-09-05       Impact factor: 91.245

7.  Failure of intensive care unit support to influence mortality from pneumococcal bacteremia.

Authors:  E W Hook; C A Horton; D R Schaberg
Journal:  JAMA       Date:  1983-02-25       Impact factor: 56.272

8.  Type distribution and antibiotic sensitivity of Diplococcus pneumoniae. A five-year study in Sydney.

Authors:  D Hansman
Journal:  Med J Aust       Date:  1974-09-21       Impact factor: 7.738

9.  Pneumococcal infections.

Authors:  M R Lockley; R Wise
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-21

10.  Serotypes in pneumococcal disease. A ten year study in Australia 1970 through 1979.

Authors:  D Hansman
Journal:  Aust N Z J Med       Date:  1983-08
View more
  5 in total

1.  Genetic relatedness within serotypes of penicillin-susceptible Streptococcus pneumoniae isolates.

Authors:  K Overweg; D Bogaert; M Sluijter; J Yother; J Dankert; R de Groot; P W Hermans
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

Review 2.  Pneumococcal resistance to antibiotics.

Authors:  K P Klugman
Journal:  Clin Microbiol Rev       Date:  1990-04       Impact factor: 26.132

3.  An unusual pneumococcal sequence type is the predominant cause of serotype 3 invasive disease in South Africa.

Authors:  Kedibone M Mothibeli; Mignon du Plessis; Anne von Gottberg; Linda de Gouveia; Peter Adrian; Shabir A Madhi; Keith P Klugman
Journal:  J Clin Microbiol       Date:  2009-11-04       Impact factor: 5.948

4.  Maternal immunity and antibody response of neonatal mice to pneumococcal type 19F polysaccharide.

Authors:  C J Lee; E D Ching; J H Vickers
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

5.  Fluoroquinolone and macrolide treatment failure in pneumococcal pneumonia and selection of multidrug-resistant isolates.

Authors:  Emilio Pérez-Trallero; José M Marimon; Luis Iglesias; Julián Larruskain
Journal:  Emerg Infect Dis       Date:  2003-09       Impact factor: 6.883
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.